Third PIPERSKA workshop on The managed introduction of new medicines
11–13 May 2015, Warsaw, Poland
The third PIPERSKA workshop will be held in Warsaw, Poland, on 11–13 May 2015 co-organized with the Agency for Health Technology Assessment (HTA), Poland and WHO/Europe. This course is intended for health care professionals involved with decision-making for funding new drugs and/or managing their introduction in Europe.
Topics to be covered include:
- principles of clinical pharmacology and the appropriate use of medicines
- HTA and the managed entry of new medicines
- horizon scanning activities, forecasting and critical drug evaluation activities
- regulatory pathways especially for biotherapeutic products including biosimilars; off-label use of medicines
- biosimilars, procurement strategy; purchasing systems and impact of tenders
- critical evaluation of new medicines; use of databases to monitor effectiveness and expenditure on new medicines in clinical care; budgeting of new medicines
- dealing with uncertainty in health economic submissions and evaluations
- risk sharing arrangements (from a payer perspective) including coverage with evidence schemes
- influencing prescribing behaviour
- prescribing and outcome monitoring including the development of quality indicators
- local formulary development
- developing an essential medicines/ priority list of oncology medicines
This highly interactive event will provide a forum for active discussion on key issues over 3 days.
